Document is current
Any future updates will be listed below
-
Authors
Alcantara, R. http://orcid.org/0000-0003-4365-5640
Posso, M.
Pitarch, M.
Arenas, N.
Ejarque, B.
Iotti, V.
Besutti, G.
- License Information
-
More Information
Article History
Received: 2 March 2022
Revised: 23 May 2022
Accepted: 30 June 2022
First Online: 27 July 2022
Declarations
:
: The scientific guarantor of this publication is Dr. R. Alcantara.
: The authors of this manuscript declare relationships with the following companies:R. A. declares to be a member of speakers’ bureau for Bard BD and GE Healthcare. V.I. declares to be a member of speakers’ bureau for GE Healthcare. All other authors declare that they have no competing interests.General Electric provided the CEM-guided biopsy software to be validated. However, this provision played no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.
: One of the authors (M. Posso) has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • Retrospective review of prospectively enrolled cohort• Pre-marketing clinical validation• Performed at one institution
